Trial
NCT04581915
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Wits Health Consortium (Pty) Ltd
Collaborators
PharmaCentrix (Pty) Ltd; Perinatal HIV Research Unit of the University of the Witswatersrand
Condition
Covid19
Intervention
Triazavirin (Riamilovir)
Why stopped
DSMB report
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-02